{"id":13291,"date":"2016-08-26T00:00:00","date_gmt":"2016-08-26T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/remsimpact\/"},"modified":"2019-03-01T12:12:25","modified_gmt":"2019-03-01T12:12:25","slug":"remsimpact","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/remsimpact\/","title":{"rendered":"REMS Impact on Pharma Marketing Survey"},"content":{"rendered":"

REMS Impact on Pharma Marketing Survey <\/p>\n

Survey began 10 August 2009<\/p>\n

This survey solicits your opinion on the impact of REMS on pharma marketing.<\/p>\n

Take the survey here<\/a><\/b>. <\/p>\n See Resources & Further Reading below…<\/a><\/p>\n

Background<\/b> Risk management. REMS (Risk Evaluation and Mitigation Strategy). Danger management of your product’s life cycle. <\/p>\n

These topics are all crucial to brand managers and marketing executives. Did you know that a Risk Evaluation and Mitigation Strategy (REMS) can be a win-win-win situation for you, your product, and the patient? Or that the longer you wait in the product development process to start thinking about REMS, the more you will lose control of your product’s future? <\/p>\n

A Risk Evaluation and Mitigation Strategy (REMS) is a strategy to manage a known or potential serious risk associated with a drug or biological product. A REMS will be required if FDA finds that a REMS is necessary to ensure that the benefits of the drug or biological product outweigh the risks of the product, and FDA notifies the sponsor. A REMS can include a Medication Guide, Patient Package Insert, a communication plan, elements to assure safe use, and an implementation system, and must include a timetable for assessment of the REMS. <\/p>\n

Survey questions include: <\/p>\n